Location History:
- Raleigh, NC (US) (2000 - 2002)
- Cary, NC (US) (2002)
- Winston Salem, NC (US) (2005 - 2017)
Company Filing History:
12 out of 1,440 
6 out of 23 
2 out of 3 Years Active: 2000-2017
Title: Innovations in Oncology: The Contributions of Jeffrey S. Mueller
Introduction
Jeffrey S. Mueller, based in Raleigh, NC, is a prominent inventor with a notable portfolio comprising 13 patents. His work primarily focuses on advancements in healthcare technology, particularly in oncology, where he has developed innovative systems and methods for patient monitoring during cancer treatment.
Latest Patents
Among his latest patents, Mueller has developed "Methods and systems for monitoring patients undergoing treatment for cancer." This patent involves oncology monitoring systems equipped with a first plurality of radiation sensors, which are strategically placed near a target tumor treatment site. These sensors gather radiation data and communicate with a portable receiver that tracks variations in this data over time, aiding medical professionals in providing dynamic tumor site information.
Another significant contribution is his patent for "Implantable devices for dynamic monitoring of physiological and biological properties of tumors." This invention features biocompatible sensors designed for implantation, which communicate with numerous remote sensor bodies to detect crucial physiological parameters in vivo. These advancements enhance the ability to monitor tumors effectively, showcasing Mueller’s commitment to improving patient care.
Career Highlights
Throughout his career, Mueller has partnered with distinguished institutions and organizations, including North Carolina State University and Sicel Technologies, Inc. His innovative contributions have positioned him as a notable figure in the realm of medical technology, where his inventions are pushing the boundaries of patient monitoring and treatment methodologies.
Collaborations
Jeffrey S. Mueller's work has been enriched through collaborations with esteemed colleagues in the industry, such as H. Troy Nagle and Charles W. Scarantino. Their combined expertise has significantly propelled their research and development efforts, resulting in patents that hold substantial promise for enhancing cancer treatment protocols.
Conclusion
Jeffrey S. Mueller stands out as a trailblazer in the intersection of technology and healthcare, particularly in oncology. His 13 patents, focusing on advanced patient monitoring systems and implantable devices, reflect his innovative approach to addressing critical challenges in cancer treatment. Through continued collaborations and research, Mueller undoubtedly plays a pivotal role in shaping the future of medical technology.